Cyclooxygenase in biology and disease
- PMID: 9737710
Cyclooxygenase in biology and disease
Abstract
Cyclooxygenase (COX), the key enzyme required for the conversion of arachidonic acid to prostaglandins was first identified over 20 years ago. Drugs, like aspirin, that inhibit cyclooxygenase activity have been available to the public for about 100 years. In the past decade, however, more progress has been made in understanding the role of cyclooxygenase enzymes in biology and disease than at any other time in history. Two cyclooxygenase isoforms have been identified and are referred to as COX-1 and COX-2. Under many circumstances the COX-1 enzyme is produced constitutively (i.e., gastric mucosa) whereas COX-2 is inducible (i.e., sites of inflammation). Here, we summarize the current understanding of the role of cyclooxygenase-1 and -2 in different physiological situations and disease processes ranging from inflammation to cancer. We have attempted to include all of the most relevant material in the field, but due to the rapid progress in this area of research we apologize that certain recent findings may have been left out.
Comment in
-
From molecular analysis to medical practice: recent studies reveal new therapeutic _targets for an old medicine.FASEB J. 1998 Sep;12(12):1061. doi: 10.1096/fasebj.12.12.1061. FASEB J. 1998. PMID: 9737709 No abstract available.
Similar articles
-
Cyclooxygenase-2: a therapeutic _target.Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952. Annu Rev Med. 2002. PMID: 11818462 Review.
-
Regulation of cyclo-oxygenase-2.Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):787-800. doi: 10.1053/bega.2001.0235. Best Pract Res Clin Gastroenterol. 2001. PMID: 11566041 Review.
-
Distribution of COX-1 and COX-2 in normal and inflamed tissues.Adv Exp Med Biol. 1997;400A:167-70. doi: 10.1007/978-1-4615-5325-0_24. Adv Exp Med Biol. 1997. PMID: 9547553
-
Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.Methods Find Exp Clin Pharmacol. 2000 Jun;22(5):291-8. doi: 10.1358/mf.2000.22.5.796648. Methods Find Exp Clin Pharmacol. 2000. PMID: 11031730 Review.
-
Dual acting anti-inflammatory drugs: a reappraisal.Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872. Pharmacol Res. 2001. PMID: 11735348 Review.
Cited by
-
Roseobacter sinensis sp. nov., a marine bacterium capable to synthesize arachidonic acid.Antonie Van Leeuwenhoek. 2024 Oct 29;118(1):24. doi: 10.1007/s10482-024-02034-z. Antonie Van Leeuwenhoek. 2024. PMID: 39472387
-
Spatiotemporally distinct roles of cyclooxygenase-1 and cyclooxygenase-2 at fetomaternal interface in mice.JCI Insight. 2024 Aug 27;9(19):e181865. doi: 10.1172/jci.insight.181865. JCI Insight. 2024. PMID: 39377223 Free PMC article.
-
12/15-Lipooxygenase Inhibition Reduces Microvessel Constriction and Microthrombi After Subarachnoid Hemorrhage in Mice.Transl Stroke Res. 2024 Sep 19. doi: 10.1007/s12975-024-01295-0. Online ahead of print. Transl Stroke Res. 2024. PMID: 39294532
-
Involvement of heparanase in the pathogenesis of acute pancreatitis: Implication of novel therapeutic approaches.J Cell Mol Med. 2024 Sep;28(17):e18512. doi: 10.1111/jcmm.18512. J Cell Mol Med. 2024. PMID: 39248454 Free PMC article.
-
Paeonol alleviates ulcerative colitis by modulating PPAR-γ and nuclear factor-κB activation.Sci Rep. 2024 Aug 8;14(1):18390. doi: 10.1038/s41598-024-68992-6. Sci Rep. 2024. PMID: 39117680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous